Piramal Diagnostics In Sell-off Talks With SRL; 20 Percent Annual Growth Draws Big Investors To India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - After the company has vehemently denied rumors on the topic in the past, strong speculation has resurfaced that India's Piramal Diagnostics is close to selling off its diagnostics business to Malvinder Singh-controlled SRL - known earlier as Specialty Ranbaxy Laboratories